UNSPSC 51343200: Antiviral pyrrolidinones and quinolines and thiazoles

This classification denotes Antiviral drugs made from or based in part on pyrrolidinones, quinolines, or thiazoles

UNSPSC 51343200 Antiviral pyrrolidinones and quinolines and thiazoles, a Class code, does not align with the state and local procurement activity tagged under it. The recent opportunities posted under this code include antibiotic tablets (doxycycline hyclate and ciprofloxacin hydrochloride) and naloxone with drug deactivation systems — products outside the antiviral pyrrolidinone, quinoline, and thiazole drug families that the code nominally describes. The mismatch between the code's pharmaceutical taxonomy and the actual goods being procured suggests either miscoding in state and local procurement systems or inconsistent application of UNSPSC classifications across issuing bodies.

The two recent opportunities show activity from the Illinois Department of Public Health and Seminole County, Florida. The Illinois Department of Public Health awarded a $2,999,999.11 pharmaceutical warehouse piggyback contract through the MMCAP Infuse consortium to Chartwell Rx LLC on August 28, 2026, for antibiotic supply under an Invitation for Bid process with a 12-month initial term and renewal options through year 3. Seminole County, Florida released an IFB (IFB60459723LAS) on June 30, 2026, for 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida, with a response deadline of July 26, 2026. Neither opportunity is driven by the code's nominal antiviral scope, and both reflect public health supply procurement rather than antiviral drug procurement specifically.